Recent changes in the treatment of patients with advanced laryngeal cancer

Head and Neck

Volumn 30, Issue 1, 2008, Pages 103-110

  Genden, Eric M ^a   Ferlito, Alfio ^b   Rinaldo, Alessandra ^b   Silver, Carl E ^c   Fagan, Johannes J ^d   Suárez, Carlos ^e,f   Langendijk, Johannes A ^g   Lefebvre, Jean Louis ^h   Bradley, Patrick J ⁱ   Leemans, C René ^j   Chen, Amy Y ^k   Jose, Jemy ^l   Wolf, Gregory T ^m  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF UDINE   (Italy)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h CENTRE OSCAR LAMBRET   (France)

ⁱ QUEEN S MEDICAL CENTRE   (United Kingdom)

^j VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l HULL ROYAL INFIRMARY   (United Kingdom)

^m UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

more..

Author keywords

Advanced laryngeal cancer; Chemoradiotherapy; Chemotherapy; Molecular therapy; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; CISPLATIN; ERLOTINIB; FLUOROURACIL; GEFITINIB;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; AGE DISTRIBUTION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE COST; HUMAN; LARYNGECTOMY; LARYNX CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; REVIEW; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; ANTINEOPLASTIC AGENTS; DEGLUTITION DISORDERS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; NEOADJUVANT THERAPY; PROTEIN KINASE INHIBITORS; QUALITY OF LIFE; RECEPTOR, EPIDERMAL GROWTH FACTOR; XEROSTOMIA;

EID: 38549161128     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20715     Document Type: Review

References (42)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
2. Chen AY, Schrag N, Hao Y, et al. Changes in treatment of advanced laryngeal cancer 1985-2001. Otolaryngol Head Neck Surg 2006;135:831-837.
3. Ferlito A. Advanced laryngeal cancer. In: Johnson JT, Didolkar MS, editors. Third International Conference on Head and Neck Cancer, San Francisco, CA, 1992. Amsterdam: Elsevier; 1993. pp 257-258.
4. National Comprehensive Cancer Network. Clinical practice guidelines in head and neck cancers. 2006. Available at www.nccn.org.
5. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-1690.
6. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098.
7. Holsinger FC, Laccourreye O, Weinstein GS, Diaz EM Jr, McWhorter AJ. Technical refinements in the supracricoid partial laryngectomy to optimize functional outcomes. J Am Coll Surg 2005;201:809-820.
8. Weinstein GS, Myers EN, Shapshay SM, Weber R. Non-surgical treatment of laryngeal cancer. N Engl J Med 2004;350:1049-1053; author reply 1049-1053.
9. Lefebvre JL. Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol 2006;7:747-755.
10. Foote RL, Foote RT, Brown PD, Garces YI, Okuno SH, Strome SE. Organ preservation for advanced laryngeal carcinoma. Head Neck 2006;28:689-696; Erratum in: Head Neck 2007;29:87.
11. Weber RS, Forastiere A, Rosenthal DI, Laccourreye O. Controversies in the management of advanced laryngeal squamous cell carcinoma. Cancer 2004;101:211-219.
12. Urba S, Wolf G, Eisbruch A, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol 2006;24:593-598.
13. Majem M, Mesia R, Manos M, et al. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma. Laryngoscope 2006;116:1651-1656.
14. Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg 2003;129:44-49.
15. American Society of Clinical Oncology, Pfister DG, Laurie SA, Weinstein GS, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006;24:3693-3704.
16. Bonfils P, Trotoux J, Bassot V. Chemotherapy alone in laryngeal squamous cell carcinoma. J Laryngol Otol 2007;121:143-148.
17. Worden F, Wolf G, Eisbruch A, et al. Neoadjuvant chemo-selection of patients for organ preservation in advanced laryngeal cancer: failure of chemotherapy as definitive treatment for complete responders to neoadjuvant therapy. Proc Am Soc Clin Oncol (in press).
18. Leon X, Hitt R, Constenla M, et al. A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy. Clin Oncol (R Coll Radiol) 2005;17:418-424.
19. Pomerantz RG, Grandis JR. The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. Semin Oncol 2004;31:734-743.
20. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-578.
21. Cohen EEW. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2006;24:2659-2665.
22. Ferlito A, Shaha AR, Lefebvre JL, Silver CE, Rinaldo A. Organ and voice preservation in advanced laryngeal cancer. Acta Otolaryngol 2002;122:438-442.
23. Herranz Gonzalez-Botas J, Gavilan Bouzas J. [Quality of life and cancer of the larynx]. Acta Otorrinolaringol Esp 1999;50:276-282 (in Spanish).
24. Dworkin JP, Hill SL, Stachler RJ, Meleca RJ, Kewson D. Swallowing function outcomes following nonsurgical therapy for advanced-stage laryngeal carcinoma. Dysphagia 2006;21:66-74.
25. Koch WM, Lee DJ, Eisele DW, et al. Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1995;121:974-980.
26. List MA, Siston A, Haraf D, et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 1999;17:1020-1028.
27. Lazarus CL, Logemann JA, Pauloski BR, et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996;106:1157-1166.
28. Fung K, Lyden TH, Lee J, et al. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 2005;63:1395-1399.
29. Nguyen NP, Moltz CC, Frank C, et al. Aspiration rate following nonsurgical therapy for laryngeal cancer. ORL J Otorhinolaryngol Relat Spec 2007;69:116-120.
30. Zbären P, Caversaccio M, Thoeny HC, Nuyens M, Curschmann J, Stauffer E. Radionecrosis or tumor recurrence after radiation of laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg 2006;135:838-843.
31. Hanna E, Sherman A, Cash D, et al. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 2004;130:875-879.
32. Davis GE, Schwartz SR, Veenstra DL, Yueh B. Cost comparison of surgery vs organ preservation for laryngeal cancer. Arch Otolaryngol Head Neck Surg 2005;131:21-26.
33. Department of health and human services report on aging. 2002. Available at www.aoa.gov.
34. Bourhis J, LeMaitre A, Pignon J, et al., for MACH-NC MARCH Groups. Impact of age on treatment effect in locally advanced head and neck cancer: two individual patient data meta-analyses. Proc Am Soc Clin Oncol 2006;24:280s.
35. Clayman GL, Eicher SA, Sicard MW, Razmpa E, Goepfert H. Surgical outcomes in head and neck cancer patients 80 years of age and older. Head Neck 1998;20:216-223.
36. Chin R, Fisher RJ, Smee RI, Barton MB. Oropharyngeal cancer in the elderly. Int J Radiat Oncol Biol Phys 1995;32:1007-1016.
37. Karl RC, Smith SK, Fabri PJ. Validity of major cancer operations in elderly patients. Ann Surg Oncol 1995;2:107-113.
38. Greimel ER, Padilla GV, Grant MM. Physical and psychosocial outcomes in cancer patients: a comparison of different age groups. Br J Cancer 1997;76:251-255.
39. Genden EM, Rinaldo A, Shaha AR, et al. Treatment considerations for head and neck cancer in the elderly. J Laryngol Otol 2005;119:169-174.
40. Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg 2006;203:865-877.
41. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006;116(Suppl 111):1-13.
42. Goepfert H. Advanced laryngeal cancer: current best management: "the paradigm is shifting, but not much." Curr Opin Otolaryngol Head Neck Surg 2002;10:112-117.